HDAC6 and neuropathy: Our findings open the way for the development of novel HDAC6 selective inhibitors for the treatment of neuropathies and other diseases, but they also point to the intriguing possibility to use oxadiazoles in the development of selective inhibitors of other HDAC subtypes.